Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography

Published:2011-12-23 Issue:3 Volume:103 Page:600-605
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Achmad Arifudin,Hanaoka Hirofumi,Yoshioka Hiroki,Yamamoto Shinji,Tominaga Hideyuki,Araki Takuya,Ohshima Yasuhiro,Oriuchi Noboru,Endo Keigo

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2011.02166.x/fullpdf

Reference39 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment;Van Cutsem;Ann Oncol,2010

3. Cancer Statistics, 2010;Jemal;CA-Cancer J Clin,2010

4. Colon Cancer;Engstrom;J Natl Compr Canc Netw,2009

5. Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials;Liu;Cancer Chemoth Pharm,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies;Clinical and Translational Medicine;2024-05-28

2. Preparation, quality control, and absorbed dose estimation of 89Zr-DFO-Cetuximab for imaging of EGFR-expressing tumors;Journal of Radioanalytical and Nuclear Chemistry;2024-04-26

3. Monoclonal Antibodies and Immuno-PET Imaging: An Overview;Fabad Journal of Pharmaceutical Sciences;2023-01-18

4. Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?;Pharmaceutics;2022-10-04

5. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates;Pharmaceutics;2022-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3